Stocktoria
Summit Therapeutics Inc. SMMT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-10-14
Summit Therapeutics Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 7,898,585 | $61.6M |
| D. E. Shaw & Co., Inc. | 2,242,229 | $42.5M |
| CITADEL ADVISORS LLC | 1,060,943 | $20.1M |
| TWO SIGMA INVESTMENTS, LP | 981,185 | $18.6M |
| Point72 Asset Management, L.P. | 801,086 | $15.2M |
| AQR CAPITAL MANAGEMENT LLC | 443,757 | $8.1M |
| MILLENNIUM MANAGEMENT LLC | 126,273 | $2.4M |
Source: SEC EDGAR filings · CIK 0001599298 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.